ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2337

Depression, Bad Sleep Quality, and Functional Deficit Are Independently Associated with Persistent Fatigue in Arthritic Patients with Low Disease Activity Under Biological Dmards

Vitalie Nizeica1, Myriam Normand2, Delphine Denarie1, Béatrice Pallot Prades1, Philippe Collet1, Adamah Amouzougan1, Hervé Locrelle1,2, Thierry Thomas1,2 and Hubert Marotte1,2, 1Rheumatology Department, University Hospital of Saint-Etienne, Saint-Etienne, France, 2INSERM U1059/LBTO, Université de Lyon - Université Jean Monnet, Saint-Etienne, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Fatigue, rheumatoid arthritis (RA) and spondylarthropathy

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: In rheumatoid arthritis (RA) or axial spondyloarthritis (axSpA) patients, fatigue has been mainly related to disease activity. Current management of rheumatic inflammatory diseases aims for low disease activity as the desirable target. However, many arthritic patients with such a therapeutic response still report severe fatigue with negative consequences on their quality of life. The main objective of our study was to investigate the potential mechanisms of this fatigue by exploring factors associated with fatigue in low-activity RA and axSpA patients.

Methods: Arthritic patients with low disease activity (DAS28<3.2 for RA or BASDAI<4/10 and ASDAS<2.1 for axSpA) were enrolled in a monocentric observational and cross-sectional study. All patients were treated with a bDMARD associated or not with conventional synthetic (cs)DMARD. All patients were successively enrolled in this study. Demographic, clinical and biological patient characteristics were recorded. Fatigue was assessed by a validated self-questionnaire FACIT-F and by VAS for fatigue. Anxiety and depression were estimated by HAD scores. Physical activity was assessed by a validated score IPAQ-SF. Sleep quality was assessed using the PSQI score. Function disability was evaluated with HAQ. Function disability was evaluated with HAQ.

Results: One hundred patients were included in the study with 55 RA (86% female) and 45 axSpA (68% men), with a mean disease duration of 11.9 ± 7.9 years. Furthermore, higher levels of physical activity together with lower functional disabilities were observed in axSpA patients compared to RA patients (Table 1). Notably, fatigue level was similar in RA and axSpA patients.

After the univariate statistical analysis, 7 parameters were statistically correlated with FACIT-F in our whole population: age, gender, sleep quality (PSQI and number of nighttime awakenings), anxiety (HAD anxiety), depression (HAD depression), and functional disability (HAQ). Four parameters remained positively associated with fatigue in the multiple linear regression: age, sleep quality (PSQI), depression (HAD depression), and functional disability (HAQ). Similar results were obtained when adding arthritic disease type (either RA or axSpA) in the multivariate analysis. Further analyses using ANCOVA test identified higher association between handicap and fatigue in axSpA patients than in RA patients. Fatigue level increased with higher handicap (p<0.001) and this trend was stronger in axSpA patients (p<0.05).  Fatigue also increased with higher depression (p<0.001), with higher age (p<0.05), and sleep quality (p<0.05), but the strength of these associations was similar in both RA and axSpA patients.

Conclusion: Our study suggests the importance of advance care of depression, sleep quality, and functional deficit in patients with low-activity RA or axSpA in order to improve their state of fatigue and consequently to increase their quality of life.


Disclosure: V. Nizeica, None; M. Normand, None; D. Denarie, None; B. Pallot Prades, None; P. Collet, None; A. Amouzougan, None; H. Locrelle, None; T. Thomas, None; H. Marotte, None.

To cite this abstract in AMA style:

Nizeica V, Normand M, Denarie D, Pallot Prades B, Collet P, Amouzougan A, Locrelle H, Thomas T, Marotte H. Depression, Bad Sleep Quality, and Functional Deficit Are Independently Associated with Persistent Fatigue in Arthritic Patients with Low Disease Activity Under Biological Dmards [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/depression-bad-sleep-quality-and-functional-deficit-are-independently-associated-with-persistent-fatigue-in-arthritic-patients-with-low-disease-activity-under-biological-dmards/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/depression-bad-sleep-quality-and-functional-deficit-are-independently-associated-with-persistent-fatigue-in-arthritic-patients-with-low-disease-activity-under-biological-dmards/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology